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We evaluated the presence of air contamination with carbape-
nem-resistant Acinetobacter baumannii (CRAB) in medical
units where patients with CRAB pneumonia were hospitalized,
and in Obstetrics and Gynecology units with open-air ventila-
tion in-patient settings. There was no evidence of CRAB con-
tamination in either of the units.
Keywords. Acinetobacter baumannii; aerosolization;
carbapenem-resistant; Thailand; ventilator-associated pneumonia.
Carbapenem-resistant Acinetobacter baumannii (CRAB) has
emerged as a major cause of healthcare-associated infections
(HAIs) globally, especially in Southeast Asian countries [1, 2]. In
Thailand, CRAB was the most common pathogen associated with
HAIs, and it has become an infection prevention and control chal-
lenge [3–5]. According to the National Antimicrobial Resistance
Surveillance Centre reports, CRAB has been on the rise since 2000,
and the carbapenem-resistant rate of Acinetobacter calcoaceticus-
baumannii complex was estimated to be >73% in 2015 [6]. This
high rateof resistancehasgreatly limited the therapeuticoptions.Ex-
isting evidence focusing on the frequency of air contamination sug-
gested the presence ofA baumannii in different units in the United
States [7–9].Therefore,weperformedanexperiment to ascertain the
presence of air contaminationwith CRAB in a hospital in Thailand.
METHODS
Setting
Thammasart University Hospital is a 650-bed tertiary care hos-
pital in central Thailand. The hospital has 17 in-patient care
departments with 8 intensive care units (ICUs). All units except
ICUs were open-air ventilation units with open windows and
doors. All patients with CRAB pneumonia who were on venti-
lators were admitted to units throughout the hospital, where a
cohorting area per unit was created as an infection control strat-
egy to contain spread of CRAB. There is no central heating ven-
tilation and air conditioning in any open unit.
Air Sampling and Data Collection
From January 4 to January 30, 2015, twice-weekly air sampling
was performed to evaluate the presence of air contamination
with CRAB in 4 different units. Units selected for study were
2 open medical care units that housed close-circuit ventilated
CRAB patients (experimental units) and 2 open Obstetrics
and Gynecology units (control units) that did not house pa-
tients with CRAB. In this hospital, a carbapenem is a commonly
used antibiotic for empirical therapy in Medicine units and
ICUs, whereas noncarbapenem β-lactam antibiotics are com-
monly used for empirical therapy in Obstetrics and Gynecology
units. Acinetobacter baumannii identification was performed
using Vitek 2 System (BioMérieux). Isolation of Acinetobacter
spp was excluded from the analysis.
For the experimental units, air sampling was performed at
the cohort area where patients’ sputum cultures were positive
at the time of air sampling. Air samples were also performed
in the control units, which housed no patient positive to
CRAB. The endemic rate of CRAB infections and colonization
in the experimental units were 7.9 patients/1000 patient-days
during the study period. The proportion of CRAB was at 65%
of all Acinetobacter isolates. Twice-weekly air sampling was per-
formed using the settle plate method, a standard technique that
had been previously validated at this hospital [10]. Passive air
sampling was performed by exposing 90 mm settle plates con-
taining sheep blood agar medium to the air for 6 hours in all
units. At each site, 2 settle plates were placed in the vicinity at
the bedside of each ventilated patient with CRAB pneumonia in
experimental units and 2 settle plates were placed in the vicinity
at the bedside of each patient in control units; all plates were
placed at 1-meter above the floor. In each location, a total of
4 plates were placed over a 24-hour period; each plate was left
opened for 6 hours and was streaked within 1 hour after the ex-
posure period. The distance between patient bed and the vicin-
ity where the plate was placed was 0.5 meter. All samples were
incubated for 5 days at 32°C. The bacterial colony counts were
expressed as forming units (CFUs)/mm3 and were estimated
using the Koch sedimentation method according to Polish Stan-
dard PN89/Z-04008/08 and the following equation: CFUs/
mm3 = (the number of colonies on Petri plate × 1000)/the
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surface area in Petri plate in cm2 × the time of Petri Plate expo-
sure in minutes × 0.2) [11]. Temperature and humidity were
measured once at the time of air sampling using Q-TRAK in-
door air quality meter 7565 (TSI, Inc., Shoreview, MN).
Data Collection
Data that were prospectively collected included patient charac-
teristics, the rate of A baumannii infection in each of the units,
the proportion of ventilated patients, patient-days, and CFUs of
bacteria per cubic square meter for each patient. The average
bacterial air bioburden value at each site was used for analysis.
Analyses were performed using IBM SPSS Statistics, version 20
(SPSS Inc., Armonk, NY). A χ2 or Fisher exact test was used to
compare categorical data, as appropriate. Continuous variables
were compared using Mann-Whitney U test. All P values were
2-tailed; P < .05 was considered statistically significant.
RESULTS
Patient characteristics were significantly different between exper-
imental vs control units (Table). In the experimental unit, venti-
lated patients consisted of 39% (69 of 180) of the patient
population and 64% (1049 of 1640) of the patient-days, whereas
there was no ventilated patient in the control units. The median
proportion of A baumannii-positive patients was 20% (range,
18%–25%) in experimental units vs 0% in the control units on
the specific days that air sampling was performed. The median
density of A baumannii was 7.1 cases/1000 vs 0 cases/1000 pa-
tient-days in experimental vs control units (P < .001), respective-
ly. The air humidity and temperature of experimental and control
units were similar (Table 1). There were 856 patient areas that
were cultured: 434 in experimental units and 422 in control
units. The median number of bacterial colonies on air sampling
was 781 vs 514 CFU/mm3 in experimental units vs control units
(P < .001), respectively. Multiple microorganisms were isolated
from the air sampling; however, the patterns were different
from experimental vs control units: Corynebacterium spp (240
vs 860 CFU/mm3; P = .02), Staphylococcus coagulase negative
(440 vs 660 CFU/mm3; P = .04), Micrococcus spp (440 vs 860
CFU/mm3; P = .01), Proteus mirabilis (651 vs 106 CFU/mm3;
P = .001), nonfermentative Gram-negative rods—not Pseudomo-
nas spp or Acinetobacter spp—(151 vs 54 CFU/mm3; P = .001).
Acinetobacter baumannii did not grow in any of the plates.
There was no difference in the patterns of all isolated organisms
in an individual unit among experimental vs control units.
Table 1. Patient-Level, Unit-Level Characteristics and Air Sampling Among Experimental and Control Units
Variables Experimental Units Control Units P Value
Unit-level characteristics
Total patients 180 180
Ventilated patients 69 (39%) 0 (0%) <.001
Patient-days 1640 1640
Ventilator-days 1049 (49%) 0 (0%) <.001
Density of Acinetobacter baumannii (median)a 7.1 0 <.001
Patient area cultures (N) 434 422
Patient-level characteristics
Number of patient 434 422
Age (years; median, range) 56 (46–74) 28 (19–45) <.001
Underlying diseases <.001
Diabetes 198 (45.6) 45 (10.6)
Hypertension 160 (36.8) 34 (8)
Chronic pulmonary disease 165 (38) 14 (3.3)
Stroke 153 (35.2) 0 (0)
Renal disease 102 (23.5) 2 (0.4)
Density of CRAB infection/colonization 7.9/1000 PD 0/1000 PD <.001
Air sampling microorganisms (CFU/mm3)
Total bacterial count (median) 781 514 <.001
Corynebacterium spp 240 860 .02
Staphylococcus coagulase negative 440 660 .04
Micrococcus spp 440 860 .01
Proteus mirabilis 651 106 .001
Nonfermentative Gram-negative rodsb 151 54 .001
A baumannii 0 0 NA
Temperature (°C, median, range) 27.6 (25.5–28.6) 26.6 (21–28.5) .59
Relative humidity (%, median, range) 60.3 (57.3–72.4) 60.9 (57–74.1) .64
Abbreviations: CFU, colony forming unit; CRAB, carbapenem-resistant A baumannii; NA, nonapplicable; no (%), unless indicated otherwise; PD, patient-days.
a Cases/1000 PD.
b Not Pseudomonas spp and Acinetobacter spp.











There were several notable findings from this study. First, de-
spite the fact that skin microorganisms and nonfermentative
Gram-negative bacteria were identified in all units, we were
not able to detect the presence of A baumannii and CRAB in
the air despite substantial sampling time. This finding implies
that the nature of an open unit allows frequent air exchanges
and may contribute to undetectable burden of A baumannii
and CRAB in the endemic setting [7]. Thus, airborne isolation
is not indicated in patients on closed ventilator circuit with A
baumannii pneumonia in an open unit with adequate ventila-
tion. Second, we found that the pattern of bacterial air biobur-
den differed greatly between each type of unit, suggesting that
patients in different hospital units can shed different types of
airborne skin particles carrying microorganisms [12]. Thus,
the unit patient activity and the type of patients in each unit
might contribute to the type and amount of bacterial air biobur-
den detected. Third, our data contributed to the body of evi-
dence for the lack of A baumannii aerosolization among
close-circuit ventilated patients in a tropical country with high
temperature and humidity.
The report of A baumannii aerosolization has been incon-
sistent [7–9]. Although some reports claim the presence of
airborne A baumannii [7, 8], others reported the lack of aerosol-
ization [9]. Factors that may impact study findings include set-
ting of each study, baseline endemicity of A baumannii, baseline
prevalence of A baumannii rectal carrier, use of concurrent an-
tibiotics that have activity toward A baumannii, use of close
ventilator circuit, type of unit (closed vs open air unit), as
well as the frequency of air exchange in the studied unit. The
results of our study confirm the findings by Rock et al [9] who
reported the lack of air contamination of A baumannii of air
surrounding known colonized or infected patients. This finding
was likely contributed to the patients’ closed-circuit ventilator
status as well as the frequent air exchanges in the studied
units, despite using 24-hour air sampling time.
There are some limitations in this study. First, we used pas-
sive air sampling method (settle plates), which have may have a
lower sensitivity to detect bacterial air bioburden than volumet-
ric air sampling. Second, we did not collect data on the patient’s
bed activities, such as changing of linens and manipulating of
the ventilators, or other sites of colonization (eg, rectum).
Third, because all patients who had confirmed diagnosis of A
baumannii ventilator-associated pneumonia received antibiotic
therapy, this might have contributed to the lack of detection of
A baumannii in the air. Fourth, this study was only performed
during a single month at 1 hospital. Finally, it is possible that
our study contained a population that had a lower association
with air contamination rate, because we did not perform rectal
swab cultures to detect CRAB rectal colonization.
CONCLUSIONS
Our findings support existing evidence on the low to no con-
tamination of A baumannii in air among closed-circuit ventilat-
ed patients in the open ventilated patient care units. Additional
studies in different settings are needed to provide more insights
into whether airborne precautions for A baumannii are needed.
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